- Company Directors - K
- Kapoor John N
Insider Trading History of Kapoor John N
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Kapoor John N since 2005.
The trader's CIK number is 1033150.
At the time of the last reporting, Kapoor John N was the Chairman of the Boar of Insys Therapeutics, Inc.. (stock ticker symbol INSY).
Also see all insider trading activities at Insys Therapeutics, Inc..
Note that in the past
KAPOOR JOHN N also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Option Care Inc/de (OPTN) by Kapoor John N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2005 | OPTN | 0 | $0 | 2,000,000 | $26,255,000 | 0 | $0 |
Yearly summary of insider trading at Akorn Inc (AKRX) by Kapoor John N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | AKRX | 19,000 | $840,940 | 0 | $0 | 0 | $0 |
2014 | AKRX | 0 | $0 | 100,000 | $4,008,885 | 0 | $0 |
2009 | AKRX | 100,000 | $94,074 | 0 | $0 | 0 | $0 |
2008 | AKRX | 50,000 | $232,720 | 0 | $0 | 0 | $0 |
2006 | AKRX | 0 | $0 | 0 | $0 | 500,000 | $1,125,000 |
Yearly summary of insider trading at First Horizon Pharmaceutical Corp (SCRX) by Kapoor John N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2006 | SCRX | 0 | $0 | 5,000,000 | $108,530,000 | 0 | $0 |
Yearly summary of insider trading at Neopharm Inc (NEOL.PK) by Kapoor John N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2009 | NEOL.PK | 250,000 | $14,832 | 0 | $0 | 0 | $0 |
2008 | NEOL.PK | 125,000 | $84,012 | 0 | $0 | 0 | $0 |
2006 | NEOL.PK | 290,000 | $2,555,289 | 0 | $0 | 0 | $0 |
2005 | NEOL.PK | 68,500 | $556,905 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Insys Therapeutics, Inc. (INSY) by Kapoor John N
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2017 | INSY | 17,500 | $156,345 | 0 | $0 | 0 | $0 |
2016 | INSY | 55,700 | $747,694 | 0 | $0 | 0 | $0 |
2015 | INSY | 25,000 | $670,425 | 0 | $0 | 0 | $0 |
2014 | INSY | 0 | $0 | 0 | $0 | 15,991 | $181,817 |
Insider trading activities at 5 companies by Kapoor John N:
1. Option Care Inc/de (OPTN)
2. Akorn Inc (AKRX)
3. First Horizon Pharmaceutical Corp (SCRX)
4. Neopharm Inc (NEOL.PK)
5. Insys Therapeutics, Inc. (INSY)
Table 1. Insider trading of Option Care Inc/de (OPTN) by Kapoor John N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2005-08-23 | OPTN | Sale | 1,000,000 | 13.29 | 13,285,000 |
2005-05-24 | OPTN | Sale | 1,000,000 | 12.97 | 12,970,000 |
Table 2. Insider trading of Akorn Inc (AKRX) by Kapoor John N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-03-10 | AKRX | Buy | 19,000 | 44.26 | 840,940 |
2014-12-10 | AKRX | Sale | 17,700 | 41.22 | 729,594 |
2014-12-11 | AKRX | Sale | 32,300 | 41.17 | 1,329,791 |
2014-08-26 | AKRX | Sale | 50,000 | 38.99 | 1,949,500 |
2009-05-19 | AKRX | Buy | 37,500 | .99 | 37,012 |
2009-05-18 | AKRX | Buy | 62,500 | .91 | 57,062 |
2008-03-20 | AKN | Buy | 40,000 | 4.67 | 186,880 |
2008-03-19 | AKN | Buy | 5,000 | 4.66 | 23,290 |
2008-03-14 | AKN | Buy | 5,000 | 4.51 | 22,550 |
2006-03-17 | AKN | Option Ex | 500,000 | 2.25 | 1,125,000 |
Table 3. Insider trading of First Horizon Pharmaceutical Corp (SCRX) by Kapoor John N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2006-11-01 | SCRX | Sale | 1,000,000 | 20.72 | 20,720,000 |
2006-07-31 | SCRX | Sale | 1,000,000 | 19.70 | 19,700,000 |
2006-05-16 | FHRX | Sale | 1,000,000 | 23.55 | 23,550,000 |
2006-03-21 | FHRX | Sale | 2,000,000 | 22.28 | 44,560,000 |
Table 4. Insider trading of Neopharm Inc (NEOL.PK) by Kapoor John N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2009-03-11 | NEOL.PK | Buy | 22,000 | .04 | 902 |
2009-03-12 | NEOL.PK | Buy | 203,000 | .06 | 12,180 |
2009-03-13 | NEOL.PK | Buy | 25,000 | .07 | 1,750 |
2008-06-05 | NEOL | Buy | 11,500 | .83 | 9,591 |
2008-06-03 | NEOL | Buy | 20,000 | .69 | 13,700 |
2008-06-04 | NEOL | Buy | 25,000 | .72 | 17,975 |
2008-05-30 | NEOL | Buy | 9,600 | .61 | 5,894 |
2008-06-02 | NEOL | Buy | 28,500 | .67 | 19,009 |
2008-05-28 | NEOL | Buy | 30,000 | .59 | 17,610 |
2008-05-29 | NEOL | Buy | 400 | .58 | 233 |
2006-10-16 | NEOL | Buy | 5,000 | 7.94 | 39,680 |
2006-10-13 | NEOL | Buy | 5,000 | 7.48 | 37,395 |
2006-10-12 | NEOL | Buy | 5,000 | 7.20 | 36,020 |
2006-10-11 | NEOL | Buy | 5,000 | 6.64 | 33,190 |
2006-10-10 | NEOL | Buy | 5,000 | 6.81 | 34,050 |
2006-10-04 | NEOL | Buy | 5,000 | 5.46 | 27,325 |
2006-10-05 | NEOL | Buy | 10,000 | 5.58 | 55,820 |
2006-10-02 | NEOL | Buy | 5,000 | 5.38 | 26,885 |
2006-10-03 | NEOL | Buy | 5,000 | 5.57 | 27,845 |
2006-09-28 | NEOL | Buy | 20,000 | 4.86 | 97,180 |
2006-09-21 | NEOL | Buy | 20,000 | 5.00 | 99,900 |
2006-01-05 | NEOL | Buy | 200,000 | 10.20 | 2,039,999 |
2005-03-14 | NEOL | Buy | 68,500 | 8.13 | 556,905 |
Table 5. Insider trading of Insys Therapeutics, Inc. (INSY) by Kapoor John N
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2017-08-11 | INSY | Buy | 17,500 | 8.93 | 156,345 |
2016-08-12 | INSY | Buy | 5,700 | 18.57 | 105,854 |
2016-05-11 | INSY | Buy | 40,000 | 12.94 | 517,720 |
2016-05-12 | INSY | Buy | 10,000 | 12.41 | 124,120 |
2015-11-17 | INSY | Buy | 5,000 | 29.77 | 148,875 |
2015-11-12 | INSY | Buy | 10,000 | 26.35 | 263,500 |
2015-11-11 | INSY | Buy | 10,000 | 25.80 | 258,050 |
2014-05-19 | INSY | Option Ex | 15,991 | 11.37 | 181,817 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kapoor John N
(Chairman of the Boar of Insys Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.